Open
Actively Recruiting
Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging.
About
Brief Summary
The purpose of this study is to compare whether the FDA and Health Canada approved microUS is as effective as the currently used option (MRI) for imaging the prostate gland. Participants will be randomized into two groups to compare the imaging results of the current standard of care MRI and the new microUS. The study is looking to identify the most effective imaging modality to help guide whether you progress to have a prostate biopsy.
Primary Purpose
Study Type
Phase
Eligibility
Gender
Healthy Volunteers
Minimum Age
Maximum Age
Inclusion Criteria:
- Male sex;
- Age 50-70;
- PSA 3-20 and/or abnormal DRE;
- Biopsy naïve.
Exclusion Criteria:
- Prior personal history of prostate cancer;
- Prior prostate imaging using microUS or MRI;
- Contraindication to microUS or MRI;
- Testosterone replacement therapy within last 12 months; or
- Androgen deprivation therapy within last 12 months.
Join this Trial
Contact our clinical trial navigators for opportunities that may be suitable for you
Share:
Study Stats
Protocol No.
25-0089
Category
Prostate Cancer
Principal Investigator
Contact
- Keyla Morales
Location
- UCLA Westwood